ELI LILLY (LLY)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for LLY
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| LLY | Director | 54 | ["Experience in health economics research and policy", "Former economic advisor to the White House", "Health advisor to the Congressional Budget Office", "Leadership of a research and educational institution", "Involvement with medical and health system research organizations", "Experience with government perspectives in healthcare"] | ["Ethics and Compliance (Chair)", "Science and Technology"] | 2026 |
Biography sourced from the proxy statement filing.
Dr. Baicker's experience in health economics research and policy at the highest levels, including as a former economic advisor to the White House and a current health advisor to the Congressional Budget Office, provides an invaluable perspective to the board. In addition to Dr. Baicker's own high-impact research, her leadership of a preeminent research and educational institution gives her both insight into and influence over the future of health policy. Through Dr. Baicker's decades of research and policy engagement, including with respect to the effects of health system reforms of public and private insurance coverage and payment policy, she brings to the board insight and context as it oversees the company's navigation of the complex environment of government regulation, insurance reimbursement, and access to affordable care. Drawing on Dr. Baicker's experience as an advisor to both the executive and legislative branches of the U.S. government, state governments, and numerous healthcare-related commissions and committees provides a keen understanding of government perspectives in our highly regulated industry. Dr. Baicker, with extensive involvement with medical and health system research organizations, adds valuable input on the research and development landscape within the pharmaceutical industry. Age: 54 Director Since: 2011 Board Committees: Ethics and Compliance (Chair) Science and Technology Other Public Boards: None Recent Prior Public Boards: HMS Holdings Corp. Key Skills: CAREER HIGHLIGHTS University of Chicago Provost (2023 - present) Emmett Dedmon Professor, Harris School of Public Policy (2017 - present) Dean of the Harris School of Public Policy (2017 - 2023) Harvard University C. Boyden Gray Professor of Health Economics (2014 - 2017) Department of Health Policy and Management, chair (2014 - 2016) Harvard T.H. Chan School of Public Health (primary) Harvard Kennedy School of Government (secondary ) National Bureau of Economic Research Research Associate, Health Care and Public Economics Programs (2007 - present) Council of Economic Advisers, Executive Office of the President Member, confirmed by U.S. Senate (2005 - 2007) OTHER HIGHLIGHTS Panel of Health Advisers to the Congressional Budget Office Advisory Board, the National Institute for Health Care Management Editorial Board of JAMA Health Forum Trustee, the Mayo Clinic Trustee, University of Chicago Medicine (ex officio) Member, the National Academy of Medicine; the National Academy of Social Insurance; the Council on Foreign Relations; and the American Academy of Arts and Sciences